Immune response during adverse events after 17D-derived yellow fever vaccination in Europe (Q34770828)

4 August 2017

Immune response during adverse events after 17D-derived yellow fever vaccination in Europe (English)

1 reference

4 August 2017

0 references

1 reference

8

Matthias Niedrig

1 reference

4 August 2017

4

Fernando de Ory

1 reference

4 August 2017

3

Antonio Tenorio

1 reference

4 August 2017

Hi-Gung Bae

1

1 reference

4 August 2017

Cristina Domingo

2

1 reference

4 August 2017

José Muñoz

5

1 reference

4 August 2017

Paul Weber

6

1 reference

4 August 2017

Dirk E Teuwen

7

1 reference

4 August 2017

language of work or name

English

0 references

publication date

1 June 2008

1 reference

Journal of Infectious Diseases

4 August 2017

1 reference

4 August 2017

197

1 reference

4 August 2017

1577-1584

1 reference

4 August 2017

11

1 reference

Pathogenesis and pathophysiology of yellow fever

4 August 2017

1 reference

Yellow fever: epidemiology and prevention

21 January 2018

1 reference

Assessment of IgG antibodies against yellow fever virus after vaccination with 17D by different assays: neutralization test, haemagglutination inhibition test, immunofluorescence assay and ELISA.

21 January 2018

1 reference

Stability of 17D yellow fever virus vaccine using different stabilizers

21 January 2018

1 reference

High stability of yellow fever 17D-204 vaccine: a 12-year restrospective analysis of large-scale production.

21 January 2018

1 reference

Development of viremia and humoral and cellular parameters of immune activation after vaccination with yellow fever virus strain 17D: a model of human flavivirus infection

21 January 2018

1 reference

Anaphylaxis from yellow fever vaccine

21 January 2018

1 reference

Possible association of encephalitis and 17D yellow fever vaccination in a 29-year-old traveller

21 January 2018

1 reference

Encephalitis in a 13-year-old boy following 17D yellow fever vaccine

21 January 2018

1 reference

Hepatitis and death following vaccination with 17D-204 yellow fever vaccine

21 January 2018

1 reference

Clinical and epidemiological characteristics of yellow fever in Brazil: analysis of reported cases 1998-2002.

21 January 2018

1 reference

Fever and multisystem organ failure associated with 17D-204 yellow fever vaccination: a report of four cases.

21 January 2018

1 reference

Effects of yellow fever vaccination

21 January 2018

1 reference

A Belgian traveler who acquired yellow fever in the Gambia

21 January 2018

1 reference

Yellow fever vaccine-associated viscerotropic disease and death in Spain.

21 January 2018

1 reference

Phenotypic and molecular analyses of yellow fever 17DD vaccine viruses associated with serious adverse events in Brazil

21 January 2018

1 reference

Yellow fever vaccine: an updated assessment of advanced age as a risk factor for serious adverse events

21 January 2018

1 reference

Neurologic disease associated with 17D-204 yellow fever vaccination: a report of 15 cases.

21 January 2018

1 reference

Evaluation of an Indirect Immunofluorescence Assay for Detection of Immunoglobulin M (IgM) and IgG Antibodies against Yellow Fever Virus

21 January 2018

1 reference

Detection of yellow fever virus: a comparison of quantitative real-time PCR and plaque assay

21 January 2018

1 reference

Clinical proof of principle for ChimeriVax: recombinant live, attenuated vaccines against flavivirus infections

21 January 2018

1 reference

Proinflammatory cytokines and chemokines in humans with Japanese encephalitis

21 January 2018

1 reference

Upregulation of RANTES gene expression in neuroglia by Japanese encephalitis virus infection

21 January 2018

1 reference

Differential response of platelets to chemokines: RANTES non-competitively inhibits stimulatory effect of SDF-1 alpha

21 January 2018

1 reference

Yellow fever virus strains Asibi and 17D-204 infect human umbilical cord endothelial cells and induce novel changes in gene expression

21 January 2018

1 reference

Activation of the cytokine network and unfavorable outcome in patients with yellow fever

21 January 2018

1 reference

Cytopathological changes induced by selected Brazilian flaviviruses in mouse macrophages

21 January 2018

1 reference

Markedly elevated levels of interferon (IFN)-gamma, IFN-alpha, interleukin (IL)-2, IL-10, and tumor necrosis factor-alpha associated with fatal Ebola virus infection

21 January 2018

1 reference

Dengue hemorrhagic fever in infants: a study of clinical and cytokine profiles

21 January 2018

1 reference

Yellow fever vaccination: how much is enough?

21 January 2018

1 reference

21 January 2018

Identifiers

DOI

10.1086/587844

1 reference

4 August 2017

1 reference